Apoorv Kumar

began his career in the heart of preventative medicine—vaccines—working with Bharat Biotech, one of India’s largest vaccine manufacturers. In this role, he led the commercialization of critical vaccines, including efforts to expand access to the company’s COVID-19 vaccine across global markets. His work included building out supply chains and forging long-term partnerships across Latin America, where he negotiated major contracts with multilateral agencies. 

These experiences, though deeply impactful, revealed the immense pressure that infectious diseases place on an already strained health system. This realization spurred Apoorv to explore the healthcare provider segment and its operational challenges more closely. Through consulting engagements with Marin Health and an internship with Kaiser Permanente, he immersed himself in the strategic and financial decision-making processes of health systems. Currently pursuing a dual MBA/MPH at the University of California, Berkeley, Apoorv brings a unique lens that bridges biopharma innovation, public health, and hospital operations. With a foundation in chemical engineering, he is passionate about ensuring that high-quality healthcare can be delivered as efficiently as possible to as many people as possible.